Coaches Activating Reaching and Engaging Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

400 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-04-03

Study Completion Date

2023-09-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the Team Based Advance Care Planning CAREPLAN program is to understand if a trained lay navigator who engages with patients with advanced stages of cancer can help patients in advance care planning, improve patient activation, satisfaction, quality of life, and the quality of end of life cancer care while also ensuring goal concordant cancer care at the end of life.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Engagement of Patients With Advanced Cancer

NCT02966509

End of Life Advanced Cancer Lung Neoplasm +11 more

COMPLETED NA

Empathetic Communication Facilitation Program for Early Initiation of End-of-life Discussions

NCT05045040

End of Life Care Advanced Cancer Recurrent Cancer

COMPLETED NA

Lay Health Worker Engage, Educate, and Encourage Patients to Share

NCT03699748

End of Life Cancer

COMPLETED NA

UC Health Care Planning Study

NCT04012749

Advance Care Planning Advance Directives Advanced Cancer

COMPLETED NA

Building Family Caregiver Skills Using a Simulation-Based Intervention for Care of Cancer Patients

NCT04055948

Cancer

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Stanford Cancer Institute plans to implement and evaluate several critical elements to be in alignment with the mission of the organization to provide high value care to their patients. The CAREPLAN (Coaches Activating, Reaching, and Engaging Patients in Their End of Life Care Plan) intervention is an innovative program aimed to strengthen provider-patient relationships and facilitate whole person care about matters important to patients diagnosed with advanced stages of cancer and important to patients' support network and family. The project is intended to help establish patients' Goals of Care Plan with appropriate documentation, develop, deploy, and evaluate a model of care for patients with cancer that is intended to improve clinical outcomes and their experiences with their cancer care. The intervention provides patients with lay navigators who assist them and their families in formulating and discussing their goals of care with their health care teams in hopes to engage in shared-decision making for goal concordant care. The goal of the project is to demonstrate that there is improved documentation of goals of care, patient experiences, patient activation, quality of life, and quality of care and communication and that the program helps to improve goal concordant care receipt at the end of life.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer End-of-Life

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

As part of usual care, patients with cancer are assigned to services by a lay navigator and this will be the control group.

For patients in the intervention, they will be assigned to the usual care lay navigator but will receive services by a lay navigator who is trained to engage patients in advance care planning.

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention Group Arm

Patients randomized into the intervention will be assigned a lay patient navigator who will provide information regarding early advance care planning, documentation of goals of care, and coordinating home-based care. The intervention arm will also receive usual care as provided by their local oncologists.

Group Type EXPERIMENTAL

Lay Navigator Intervention

Intervention Type BEHAVIORAL

Patients randomized into the intervention will be assigned a lay health worker who will contact the patient to begin the intervention. The intervention includes: education on early advance care planning and documenting goals of care.

Usual Care

Intervention Type OTHER

Usual care as provided by local oncologists

Control Group Arm

The control group will receive usual care as provided by their local oncologists.

Group Type ACTIVE_COMPARATOR

Usual Care

Intervention Type OTHER

Usual care as provided by local oncologists

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Lay Navigator Intervention

Patients randomized into the intervention will be assigned a lay health worker who will contact the patient to begin the intervention. The intervention includes: education on early advance care planning and documenting goals of care.

Intervention Type BEHAVIORAL

Usual Care

Usual care as provided by local oncologists

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Intervention Group Arm

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients who receive care at Stanford Cancer Institute and have genitourinary cancers and have received greater than 2 prior courses of chemotherapy treatment